Cancer patients might replace sugar with artificial sweeteners in order to eat more healthily, but they need to be aware of the possibility that sucralose may decrease the effectiveness of their treatment. — TNS
Sucralose, a common artificial sweetener, may be preventing the body from responding to cancer immunotherapy, a new study out of the University of Pittsburgh (Pitt) in the United States finds.
The results come as the US Department of Health and Human Services turns its attention toward ultraprocessed foods, with efforts to ban artificial food dyes and sweeteners.
